Literature DB >> 6489261

Production of a macromolecular bone-resorbing factor by the hypercalcemic variant of the walker rat carcinosarcoma.

S M D'Souza, K J Ibbotson, D D Smith, G R Mundy.   

Abstract

The Walker rat 256 carcinosarcoma is a spontaneous rat breast tumor which has two unique variants, one of which is always associated with severe hypercalcemia and one which is not associated with hypercalcemia when the tumor is carried im. To determine the factor responsible for hypercalcemia, we established tumor cells derived from both variants in culture and found that the tumor cells from the hypercalcemic variant release an acid-soluble and acid-stable bone-resorbing factor of approximately 25,000 mol wt. Cells from the normocalcemic variant produce no bone-resorbing activity. These data are consistent with the notion that hypercalcemia in this animal model of the humoral hypercalcemia of malignancy is due to a macromolecular bone-resorbing factor which is acid and heat stable and requires disulfide bonds for biological activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489261     DOI: 10.1210/endo-115-5-1746

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

Review 1.  Hypercalcaemia in malignancy.

Authors:  D A Heath
Journal:  BMJ       Date:  1989-06-03

2.  Human transforming growth factor-alpha stimulates bone resorption in vitro.

Authors:  P H Stern; N S Krieger; R A Nissenson; R D Williams; M E Winkler; R Derynck; G J Strewler
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.

Authors:  J E Decker; N E Morrison; J A Lorenzo; C M Samour; B A McCarron; L G Raisz
Journal:  Calcif Tissue Int       Date:  1989-01       Impact factor: 4.333

Review 4.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.